141 related articles for article (PubMed ID: 38113979)
1. Bioinformatics analysis of CMTM family in pan-cancer and preliminary exploration of CMTM6 in bladder cancer.
Xu Y; Li Q; Lin H
Cell Signal; 2024 Mar; 115():111012. PubMed ID: 38113979
[TBL] [Abstract][Full Text] [Related]
2.
Li D; Huang S; Luo C; Xu Y; Fu S; Liu K; Wu J
Curr Oncol; 2023 Feb; 30(3):2653-2672. PubMed ID: 36975415
[TBL] [Abstract][Full Text] [Related]
3. CMTM 6 promotes the development of thyroid cancer by inhibiting NIS activity through activating the MAPK signaling pathway.
Chen X; Shen H; Liu H; Tan L; Zhang N
Funct Integr Genomics; 2024 Jan; 24(1):10. PubMed ID: 38221563
[TBL] [Abstract][Full Text] [Related]
4. Autophagy-related CMTM6 promotes glioblastoma progression by activating Wnt/β-catenin pathway and acts as an onco-immunological biomarker.
Dai L; Xiao J; Li X; Tao Y; Zhou P; Lyu L; Shi Z; Liang X; Jia Z; Jiang S
J Gene Med; 2024 May; 26(5):e3685. PubMed ID: 38686653
[TBL] [Abstract][Full Text] [Related]
5. CMTM6 and PD-L1 coexpression is associated with an active immune microenvironment and a favorable prognosis in colorectal cancer.
Peng QH; Wang CH; Chen HM; Zhang RX; Pan ZZ; Lu ZH; Wang GY; Yue X; Huang W; Liu RY
J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33579737
[TBL] [Abstract][Full Text] [Related]
6. [Advances in the Study of Chemokine-like Factor Superfamily Members in Tumors].
Xie G; Cheng J; Zhang J
Zhongguo Fei Ai Za Zhi; 2023 Jan; 26(1):46-51. PubMed ID: 36792080
[TBL] [Abstract][Full Text] [Related]
7. Research insights into the chemokine-like factor (CKLF)-like MARVEL transmembrane domain-containing family (CMTM): their roles in various tumors.
Duan SL; Jiang Y; Li GQ; Fu W; Song Z; Li LN; Li J
PeerJ; 2024; 12():e16757. PubMed ID: 38223763
[TBL] [Abstract][Full Text] [Related]
8. OSCC cell-secreted exosomal CMTM6 induced M2-like macrophages polarization via ERK1/2 signaling pathway.
Pang X; Wang SS; Zhang M; Jiang J; Fan HY; Wu JS; Wang HF; Liang XH; Tang YL
Cancer Immunol Immunother; 2021 Apr; 70(4):1015-1029. PubMed ID: 33104837
[TBL] [Abstract][Full Text] [Related]
9. Impact of CKLF-like MARVEL transmembrane domain containing 6 (CMTM6) expression in gastric cancer.
Nishi M; Shimada M; Yoshikawa K; Higashijima J; Tokunaga T; Kashihara H; Takasu C; Eto S; Yoshimoto T
J Med Invest; 2021; 68(3.4):362-367. PubMed ID: 34759159
[TBL] [Abstract][Full Text] [Related]
10. Identification of prognostic biomarkers in the CMTM family genes of human ovarian cancer through bioinformatics analysis and experimental verification.
Zhang M; Wang J; Yue H; Zhang L
Front Genet; 2022; 13():918319. PubMed ID: 36110202
[No Abstract] [Full Text] [Related]
11. CMTM6 is highly expressed in lung adenocarcinoma and can be used as a biomarker of a poor diagnosis.
Jia D; Xiong L; Xue H; Li J
PeerJ; 2023; 11():e14668. PubMed ID: 36643629
[TBL] [Abstract][Full Text] [Related]
12. Differential Expression of CKLF-like MARVEL Transmembrane Domain-Containing Protein 6 and Programmed Cell Death Ligand 1 as Prognostic Biomarkers in Upper Tract Urothelial Carcinoma.
Kdimati S; Christoph C; Glass Ä; Engel N; Dräger DL; Maletzki C; Becker AS; Zimpfer A
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542462
[TBL] [Abstract][Full Text] [Related]
13. CMTM6 and CMTM4 as two novel regulators of PD-L1 modulate the tumor microenvironment.
Zhang T; Yu H; Dai X; Zhang X
Front Immunol; 2022; 13():971428. PubMed ID: 35958549
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Implications of Pan-Cancer CMTM6 Expression and Its Relationship with the Immune Microenvironment.
Zhao Y; Zhang M; Pu H; Guo S; Zhang S; Wang Y
Front Oncol; 2020; 10():585961. PubMed ID: 33552963
[TBL] [Abstract][Full Text] [Related]
15. CMTM6, a potential immunotherapy target.
Liang J; Li S; Li W; Rao W; Xu S; Meng H; Zhu F; Zhai D; Cui M; Xu D; Cai J; Zhang B
J Cancer Res Clin Oncol; 2022 Jan; 148(1):47-56. PubMed ID: 34783871
[TBL] [Abstract][Full Text] [Related]
16. CMTM family proteins 1-8: roles in cancer biological processes and potential clinical value.
Wu J; Li L; Wu S; Xu B
Cancer Biol Med; 2020 Aug; 17(3):528-542. PubMed ID: 32944388
[TBL] [Abstract][Full Text] [Related]
17. Cancer Research Advance in CKLF-like MARVEL Transmembrane Domain Containing Member Family (Review).
Lu J; Wu QQ; Zhou YB; Zhang KH; Pang BX; Li L; Sun N; Wang HS; Zhang S; Li WJ; Zheng W; Liu W
Asian Pac J Cancer Prev; 2016; 17(6):2741-4. PubMed ID: 27356683
[TBL] [Abstract][Full Text] [Related]
18. Chemokine-like factor-like MARVEL transmembrane domain-containing family in autoimmune diseases.
Duan HJ; Li XY; Liu C; Deng XL
Chin Med J (Engl); 2020 Apr; 133(8):951-958. PubMed ID: 32195671
[TBL] [Abstract][Full Text] [Related]
19. Pan-cancer analysis reveals potential immunological and prognostic roles of COA6 in human cancers and preliminary exploration of COA6 in bladder cancer.
Luo H; Wang Z
Cell Signal; 2024 May; 117():111111. PubMed ID: 38395184
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive analysis of the prognostic value of the chemokine-like factor-like MARVEL transmembrane domain-containing family in gastric cancer.
Liang Z; Xie J; Huang L; Huang Y; Zhang Y; Ma R; Zheng Z; Wang Q; Li X
J Gastrointest Oncol; 2021 Apr; 12(2):388-406. PubMed ID: 34012634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
